Discover the Galleri® multi-cancer early detection test

Are you ready for a revolution in cancer screening? At Missouri Cancer Associates, we are proud to introduce the Galleri® multi-cancer early detection (MCED) test. This innovative test has the potential to transform the way we screen for cancer when added to recommended cancer screening.

In the video below, Dr. Iliff, an MCA oncologist/hematologist, introduces the Galleri® multi-cancer early detection test at Missouri Cancer Associates. Watch to learn more about this cancer screening test, its benefits, and who can benefit from it.

What is the Galleri Multi-Cancer Early Detection Test?

The Galleri test is the first-of-its-kind cancer screening test designed to identify DNA fragments that act like a unique “fingerprint” of cancer through a simple blood test. This test screens for a “fingerprint” of many of the deadliest cancers that currently have no recommended screening tests, including fast-spreading, aggressive cancers, like pancreatic and ovarian* that don’t show symptoms in early stages. Using Galleri in addition to recommended screening tests can increase the chance of finding cancer early, when there may be more treatment options.

*Sensitivity in study participants with: Pancreatic cancer: 83.7% overall (61.9% stage I, 60.0% stage II, 85.7% stage III, 95.9% stage IV). Ovarian cancer: 83.1% overall (50.0% stage I, 80.0% stage II, 87.1% stage III, 94.7% stage IV).

Key Benefits

Screen for More Cancers

Looks for DNA in the blood that may indicate cancer.

Test with Ease

Completed with a single blood draw of about 1.5 tablespoons (20 mL) of blood.

Actionable Results

If a cancer signal is found, the results predict the tissue type or organ associated with the cancer signal to help your healthcare provider guide your next steps. Diagnostic testing is needed to confirm cancer.

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests.

Who Can Benefit?

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. This innovative blood test is meant to be used in addition to, not replace, other cancer screening tests that your healthcare provider recommends.

It’s important to note that the Galleri test doesn’t identify a signal for all types of cancer, and it doesn’t assess your genetic risk for future cancer development. False positive and false negative results do occur. Your healthcare provider can guide you on the best combination of tests to screen for cancer.

Talk to your doctor about proactive cancer screening with Galleri.

The Galleri Test Has Three Steps at MCA

 

  1. See if you qualify by completing the online questionnaire below or talk to your provider.
  2. Consult and blood draw
    1. A healthcare provider from Missouri Cancer will consult with you and order the Galleri test if appropriate.
    2. If your request is approved, the clinic will complete your blood draw during your appointment.
  3. Receive your test result. Get your results from your provider about 2 weeks after your blood draw.

Am I Eligible for the Multi-Cancer Early Detection Test?

Talk to a Healthcare Provider about the Galleri test today

Don’t wait until it’s too late. Be proactive about your cancer screening with the Galleri test. Contact Missouri Cancer Associates in Columbia, Missouri today to discuss next steps.

Important Safety Information

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Cancer Signal Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

Laboratory / Test Information

GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

The Galleri® test is not a substitute for regular check-ups and recommended cancer screenings. It is advised to consult with a healthcare professional to determine if the Galleri® test is appropriate for your health needs.

  • Sign Up
    For Our
    Your Source For:
    Advice,
    Stories,
    Upcoming
    Events,
    And More!

Schedule an Appointment

 Call: (866) 724-2413
Monday through Friday between 8:00 AM to 4:00 PM

Same day appointments are usually available Monday-Friday.

Schedule an appointment online.

Get a Second Opinion

Make an appointment with one of our medical oncologistsradiation oncologistsgenetics experts, or hematology professionals.